KKR & Co. Inc. (NYSE:KKR) is in talks to acquire a minority stake in the TIS International (USA), Inc. (Infinx Healthcare), said two people aware of the development. KKR is likely to invest about $150 million (INR 12,500 million) in Infinx to acquire about 26% stake.

Based in SanJose, CA, Infinx Healthcare works with medical billing companies, radiology groups, physician practices and long-term care pharmacies, providing complete revenue cycle management (RCM) solutions. KKR is looking to build Infinix into a platform by doing bolt-on acquisitions over time and grow it, one of the people said. When contacted Akshay Tanna, partner and head of India Private Equity, KKR told ET, ?We expect this sector to continue growing in India, driven by global demand, and believe that Infinx is well placed to meet this gap through its tech-enabled solutions.

We will draw on our local knowledge and healthcare expertise to support Infinx?s growth and build a healthcare platform, including through organic and inorganic growth strategies?. He refused to disclose further details. He added India is one of the world?s top providers of healthcare RCM solutions, given the depth of local talent and range of quality solutions.

?KKR?s investment is a testament to Infinx?s success over the past decade. Success of our customers is central to us at Infinx and with KKR?s support and experience in healthcare and technology we will be able to strengthen our capabilities to deliver innovative, AI-backed solutions to accelerate Infinx?s growth and ultimately help healthcare providers to provide exceptional care to their patients,? said Jaideep Tandon, Chief Executive Officer, Infinx Healthcare.